About Rachel Zayas
Form D filings for Active Genomes Expressed Diagnostics in 2023 list Rachel Zayas as CEO and director.
Rachel Zayas first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Rachel Zayas in the role, so the role may have started earlier or lasted longer.